GBDGlobal Subarachnoid Hemorrhage Risk Factors Collaborators
Rautalin I
Volovici V
Stark BA
Johnson CO
Kaprio J
Korja M
Krishnamurthi RV
Nair BS
Ranta A
Rinkel GJE
Vergouwen MDI
Abate YH
Abbastabar H
Abd-Allah F
Abdelkader A
Abdi P
Abdollahi A
Abdullahi A
Abiodun OO
Aboagye RG
Abouzid M
Abtahi D
Abu Rumeileh S
Abualhasan A
Abualruz H
Abukhadijah HJ
Abu-Zaid A
Adamu LH
Addo IY
Adedoyin RA
Adegboye OA
Adra S
Adzigbli LA
Agyemang-Duah W
Ahinkorah BO
Ahmad A
Ahmad D
Ahmadzade AM
Ahmed A
Ahmed H
Ahmed SA
Aji B
Akkaif MA
Al-Ajlouni Y
Al-Aly Z
Albashtawy M
Ali MU
Alif SM
Alimohamadi Y
Aljunid SM
Alomari MA
Alrawashdeh A
Alsabri MA
Salman RA
Altaf A
Al-Tammemi AB
Alvis-Guzman N
Alwafi H
Al-Wardat M
Al-Worafi YM
Aly H
Alyahya MSI
Alzoubi KH
Amani R
Amin TT
Amindarolzarbi A
Amusa GA
Anderlini D
Angappan D
Anil A
Anuoluwa BS
Anwar S
Anyasodor AE
Apostol GLC
Arabloo J
Areda D
Arnlov J
Artamonov AA
Artanti KD
Arumugam A
Aryan Z
Asghari-Jafarabadi M
Ashemo MY
Ashraf T
Athar M
Athari SS
Aujayeb A
Awotidebe AW
Azadnajafabad S
Aziz S
Azzam AY
Babu GR
Bagheri N
Bahrami Taghanaki P
Bahramian S
Bai R
Baig AA
Bako AT
Baltatu OC
Bam K
Banach M
Bandyopadhyay S
Banik B
Bardhan M
Barker-Collo SL
Barnighausen TW
Barqawi HJ
Barua L
Bastan MM
Basu S
Bell SL
Bensenor IM
Berhie AY
Beyene KA
Bhagavathula AS
Bhaskar S
Bhat AN
Bhat V
Bhatti GK
Bhatti JS
Bijani A
Bikbov B
Birhan MM
Birhanu MM
Bitra VR
Boloor A
Borhany H
Breitner S
Brenner H
Bugiardini R
Bulamu NB
Butt ZA
Cabral LS
Caetano Dos Santos FL
Calina D
Camera LA
Campos LA
Campos-Nonato I
Capodici A
Carvalho F
Castaneda-Orjuela CA
Catapano AL
Cegolon L
Chadwick J
Chakraborty C
Chakraborty PA
Chakraborty S
Chandika RM
Chanie GS
Chattu VK
Chaudhary AA
Chi G
Chichagi F
Ching PR
Chopra H
Choudhari SG
Chowdhury EK
Chu DT
Chung SC
Columbus A
Criqui MH
da Silva AG
Dabbagh Ohadi MA
Dadras O
Dai X
Dalal K
Dalli LL
D'Amico E
Dashti M
Davletov K
De la Cruz-Gongora V
Debopadhaya S
Delgado-Enciso I
Dervisevic E
Devanbu VGC
Dewan SMR
Dhane AS
Dibas M
Do TC
Do THP
Dohare S
Doheim MF
Dokova KG
Dongarwar D
D'Oria M
Doshi OP
Doshi RP
Dowou RK
Dsouza HL
Dutta S
Dziedzic AM
E'Mar A R
Edvardsson D
Efendi D
Efendi F
El Nahas N
Elgendy IY
Elhadi M
Eltaha C
Eltahir ME
Emeto TI
Fabin N
Fagbamigbe AF
Fahim A
Fakhradiyev IR
Fares J
Faris PS
Fauk NK
Fazylov T
Fekadu G
Ferreira N
Fetensa G
Fischer F
Foschi M
Fridayani NKY
Gaipov A
Gajjar AA
Gandhi AP
Ganesan B
Garg RK
Gebregergis MW
Gebrehiwot M
Gebremeskel TG
Getie M
Ghadimi DJ
Ghadirian F
Ghahramani S
Ghasemzadeh A
Ghazy RM
Gholamalizadeh M
Ghozy S
Gil AU
Gilani JA
Gnedovskaya EV
Goleij P
Goulart AC
Goulart BNG
Guan SY
Gupta S
Habibzadeh F
Hadei M
Hadi NR
Hamidi S
Hanifi N
Hankey GJ
Harlianto NI
Haro JM
Hasan F
Hasani H
Hasnain MS
Hassan Zadeh Tabatabaei MS
Haubold J
Havmoeller RJ
Hay SI
Hbid Y
Heidari G
Heidari M
Hemmati M
Hiraike Y
Hoan NQ
Holla R
Hosseinzadeh M
Hostiuc S
Huang J
Huynh HH
Hwang BF
Ibitoye SE
Ikeda N
Ikiroma A
Ilaghi M
Ilesanmi OS
Ilic IM
Ilic MD
Islam MR
Ismail NE
Iso H
Isola G
Iwagami M
Jacob L
Jafarzadeh A
Jain A
Jairoun AA
Jakovljevic M
Jatau AI
Jawaid T
Jayapal SK
Jonas JB
Joseph N
Jurisson M
Kadashetti V
Kalani R
Kamal VK
Kamireddy A
Kanchan T
Kandel H
Karami J
Karaye IM
Karimi Y
Karimi Behnagh A
Kashoo FZ
Kayode GA
Kazemi F
Kesse-Guyot E
Khader YS
Khaing IK
Khan F
Khan MJ
Khatatbeh H
Khatatbeh MM
Khayat Kashani HR
Kheirallah KA
Khidri FF
Khormali M
Khosla AA
Kim K
Kim YJ
Kisa A
Kisa S
Kivimaki M
Kolahi AA
Kompani F
Korzh O
Kostev K
Kothari N
Krishan K
Krishna V
Krishnamoorthy V
Kuddus M
Kulimbet M
Kunutsor SK
Kurniasari MD
Kusuma D
Kyto V
La Vecchia C
Lahariya C
Lai DTC
Lai H
Laksono T
Lallukka T
Latief K
Latifinaibin K
Le NHH
Le TTT
Lee M
Lee SW
Lee WC
Lee YH
Lenzi J
Leonardi M
Li MC
Li X
Lim SS
Lin J
Liu X
Lohner V
Lorenzovici L
Lotufo PA
Lucchetti G
Lusk JB
Lutzky Saute R
MAmin HI
Malhotra AK
Malhotra K
Malik AA
Malta DC
Mansournia MA
Mantovani LG
Manu E
Marateb HR
Marino M
Maroufi SF
Martinez-Piedra R
Martini S
Martorell M
Marzo RR
Mathangasinghe Y
Mathews E
Maugeri A
McPhail SM
Mehmood A
Mehndiratta MM
Mehrabani-Zeinabad K
Menezes RG
Meo SA
Meretoja A
Mestrovic T
Mettananda CDK
Miazgowski T
Micheletti Gomide Nogueira de Sa AC
Minervini G
Minh LHN
Mirica A
Mirrakhimov EM
Mirza-Aghazadeh-Attari M
Mishra AK
Mithra P
Mohamed AZ
Mohamed AI
Mohammad AM
Mohammadi S
Mohammadian-Hafshejani A
Mohammed S
Mokdad AH
Molinaro S
Momani S
Moni MA
Moodi Ghalibaf A
Moradi M
Moradi Y
Moraga P
Morawska L
Msherghi A
Munjal K
Murray CJL
Nagarajan AJ
Naik GR
Najdaghi S
Nakhostin Ansari N
Nargus S
Davani DN
Natto ZS
Nauman J
Nayak VC
Nazri-Panjaki A
Negoi RI
Nematollahi S
Newton CRJ
Nguyen DH
Nguyen HTH
Nguyen HQ
Nguyen PT
Nguyen VT
Niazi RK
Nigatu YT
Nikoobar A
Nogueira de Sa AT
Nomura S
Noubiap JJ
Nugen F
Nzoputam CI
Oancea B
Oduro MS
Ojo-Akosile TR
Okati-Aliabad H
Okeke SR
Okekunle AP
Olagunju AT
Olaiya MT
Oliveira AB
Oliveira GMM
Olorukooba AA
Olufadewa, II
Ornello R
Ortiz-Prado E
Osuagwu UL
Ouyahia A
Owolabi MO
Ozair A
P AMp
Padron-Monedero A
Padubidri JR
Panagiotakos D
Panos GD
Panos LD
Pantazopoulos I
Parikh RR
Park S
Patel J
Patel UK
Patoulias D
Pedersini P
Peprah EK
Pereira G
Perianayagam A
Perico N
Perna S
Petermann-Rocha FE
Philip AK
Piradov MA
Plotnikov E
Polibin RV
Postma MJ
Pradhan J
Prasad M
Puvvula J
Qasim NH
Qian G
Raggi A
Rahim F
Rahimi-Movaghar V
Rahman M
Rahman MA
Rahmani AM
Rahmanian M
Rajaa S
Rajabpour Sanati A
Rajpoot PL
Rajput P
Ramadan MM
Ramasamy SK
Ramazanu S
Rane A
Rashedi S
Rashidi MM
Rathish D
Rawaf S
Razo C
Reddy Mmrk
Redwan E
Remuzzi G
Rezaei N
Rezaei N
Rezaeian M
Rocha HAL
Rodriguez JAB
Roever L
Romoli M
Romozzi M
Ross AG
Rout HS
Roy N
Roy P
Saad AMA
Saadatian Z
Sabour S
Sacco S
Saddik BA
Sadeghi E
Saeed U
Saheb Sharif-Askari F
Sahebkar A
Sahoo PM
Sajib Mruz
Salaroli LB
Saleh MA
Samodra YL
Samuel VP
Samy AM
Santric-Milicevic MM
Saravanan A
Sarkar T
Sarode GS
Sarode SC
Sartorius B
Satpathy M
Schlaich MP
Schneider IJC
Schuermans A
Selvaraj S
Senthilkumaran S
Sepanlou SG
Sethi Y
Seylani A
Shaaban AN
Shafie M
Shahwan MJ
Shaikh MA
Shaikh SZ
Shamim MA
Shamsi A
Shamsutdinova A
Shanawaz M
Shannawaz M
Sharifan A
Sharifi Rad J
Sharma V
Shashamo BB
Shetty M
Shetty PK
Shigematsu M
Shittu A
Shiue I
Shlobin NA
Shorofi SA
Siddig EE
Singh B
Singh P
Singh P
Singh S
Sobia F
Solanki R
Solanki S
Soraneh S
Spartalis M
Srinivasamurthy SK
Stanaway JD
Stanikzai MH
Starodubova AV
Sun J
Sun Z
Swain CK
Szarpak L
Tabaee Damavandi P
Tabatabaei SM
Tabatabaeizadeh SA
Tabche C
Taiba J
Talaat IM
Tamuzi JL
Tan KK
Temsah MH
Teramoto M
Thakur R
Thankappan KR
Thayakaran R
Thirunavukkarasu S
Ticoalu JHV
Tiwari K
Tonelli M
Topor-Madry R
Tovani-Palone MR
Tran AT
Tran JT
Tran TH
Tran Minh Duc N
Truelsen TC
Truyen Tttt
Tsai DH
Ullah A
Unim B
Unnikrishnan B
Unsworth CA
Usman JS
Vahdati S
Vaithinathan AG
Valizadeh R
Van den Eynde J
Varghese J
Vasankari TJ
Venketasubramanian N
Vervoort D
Villafane JH
Vinayak M
Vladimirov SK
Wafa HA
Waheed Y
Wahood W
Walde MT
Wang Y
Wickramasinghe ND
Willeit P
Wolde AA
Wolfe CDA
Wubie YM
Xiao H
Xu S
Xu X
Yamagishi K
Yano Y
Yarahmadi A
Yaribeygi H
Yaya S
Ye P
Yon DK
Yonemoto N
Yu C
Zanghi A
Zare I
Zastrozhin M
Zhang C
Zhang Y
Zhang ZJ
Zhang Z
Zhao H
Zhou SC
Zhumagaliuly A
Zia H
Zielinska M
Zyoud SH
Roth GA
Feigin VL
JAMA Neurol. 2025;82765-87
IMPORTANCE: Nontraumatic subarachnoid hemorrhage (SAH) represents the third most common stroke type with unique etiologies, risk factors, diagnostics, and treatments. Nevertheless, epidemiological studies often cluster SAH with other stroke types leaving its distinct burden estimates obscure. OBJECTIVE: To estimate the worldwide burden of SAH. DESIGN, SETTING, AND PARTICIPANTS: Based on the repeated cross-sectional Global Burden of Disease (GBD) 2021 study, the global burden of SAH in 1990 to 2021 was estimated. Moreover, the SAH burden was compared with other diseases, and its associations with 14 individual risk factors were investigated with available data in the GBD 2021 study. The GBD study included the burden estimates of nontraumatic SAH among all ages in 204 countries and territories between 1990 and 2021. EXPOSURES: SAH and 14 modifiable risk factors. MAIN OUTCOMES AND MEASURES: Absolute numbers and age-standardized rates with 95% uncertainty intervals (UIs) of SAH incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) as well as risk factor-specific population attributable fractions (PAFs). RESULTS: In 2021, the global age-standardized SAH incidence was 8.3 (95% UI, 7.3-9.5), prevalence was 92.2 (95% UI, 84.1-100.6), mortality was 4.2 (95% UI, 3.7-4.8), and DALY rate was 125.2 (95% UI, 110.5-142.6) per 10ÔÇ»000 people. The highest burden estimates were found in Latin America, the Caribbean, Oceania, and high-income Asia Pacific. Although the absolute number of SAH cases increased, especially in regions with a low sociodemographic index, all age-standardized burden rates decreased between 1990 and 2021: the incidence by 28.8% (95% UI, 25.7%-31.6%), prevalence by 16.1% (95% UI, 14.8%-17.7%), mortality by 56.1% (95% UI, 40.7%-64.3%), and DALY rate by 54.6% (95% UI, 42.8%-61.9%). Of 300 diseases, SAH ranked as the 36th most common cause of death and 59th most common cause of DALY in the world. Of all worldwide SAH-related DALYs, 71.6% (95% UI, 63.8%-78.6%) were associated with the 14 modeled risk factors of which high systolic blood pressure (population attributable fraction [PAF] = 51.6%; 95% UI, 38.0%-62.6%) and smoking (PAF = 14.4%; 95% UI, 12.4%-16.5%) had the highest attribution. CONCLUSIONS AND RELEVANCE: Although the global age-standardized burden rates of SAH more than halved over the last 3 decades, SAH remained one of the most common cardiovascular and neurological causes of death and disabilities in the world, with increasing absolute case numbers. These findings suggest evidence for the potential health benefits of proactive public health planning and resource allocation toward the prevention of SAH.